![](https://investorshub.advfn.com/uicon/48355.png?cb=1551739062)
Wednesday, June 29, 2022 2:17:15 PM
12:58 pm ET June 29, 2022 (Dow Jones) Print
By Colin Kellaher
Shares of Decibel Therapeutics Inc. surged more than 30% on Wednesday, extending Tuesday's gains after the clinical-stage biotechnology company reported positive study results.
The Boston company on Tuesday said interim data from a Phase 1b study of DB-020 support continued development of the drug in the protection against ototoxicity, or hearing loss, in cancer patients receiving cisplatin chemotherapy.
Decibel said 87% of patients who experienced ototoxicity in their placebo-treated ear were protected from the side effect in their ear treated with DB-020.
In a research note, Citi analyst Neena Bitritto-Garg, who has a "buy" rating and a $15 target price on Decibel shares, said the study data mark "a clear win" the company.
The analyst also noted that Decibel remains focused on its earlier-stage gene-therapy portfolio, with an ultimate goal of licensing DB-020 to a company with an oncology sales force.
Decibel shares, which rose 18.3% on Tuesday, were recently changing hands at $3.52, up 32.9%.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
New York Yankees and Duke Basketball
Recent DBTX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 10/10/2023 08:56:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/25/2023 08:35:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/25/2023 08:32:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/25/2023 08:30:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/25/2023 08:29:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/25/2023 08:24:04 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 09/25/2023 01:09:56 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/25/2023 01:00:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 12:56:29 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 09/25/2023 12:53:55 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 09/12/2023 08:12:55 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 09/08/2023 08:23:57 PM
- Form SC 14D9 - Solicitation, recommendation statements • Edgar (US Regulatory) • 08/25/2023 01:17:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/25/2023 11:04:29 AM
- Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update • GlobeNewswire Inc. • 08/11/2023 11:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 11:30:54 AM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 08/09/2023 08:55:57 PM
- Decibel Therapeutics Shares Surge on Regeneron Acquisition • Dow Jones News • 08/09/2023 01:34:00 PM
- Regeneron To Acquire Decibel Therapeutics • Dow Jones News • 08/09/2023 12:14:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 12:02:31 PM
- Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs • GlobeNewswire Inc. • 08/09/2023 11:30:53 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM